CVE-2019-18254 — BIOTRONIK CardioMessenger II, The affected products do not encrypt sensitive inf

BIOTRONIK CardioMessenger II, The affected products do not encrypt sensitive information while at rest. An attacker with physical access to the CardioMessenger can disclose medical measurement data and the serial number from the implanted cardiac device the CardioMessenger is pai

01What is this vulnerability?

BIOTRONIK CardioMessenger II, The affected products do not encrypt sensitive information while at rest. An attacker with physical access to the CardioMessenger can disclose medical measurement data and the serial number from the implanted cardiac device the CardioMessenger is paired with.

02Affected products

Vendor	Product	Versions
n	a / BIOTRONIK CardioMessenger II	S T-Line, CardioMessenger II-S GSM — CardioMessenger II-S T-Line T4APP 2.20, CardioMessenger II-S GSM T4APP 2.20

03Active exploitation status

Not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog. EPSS is the best forward-looking signal — see the EPSS row above.

04Recommended remediation

• Patch to a fixed version listed in the vendor advisory (see references below).
• Mitigate with WAF rules, network egress filters, or feature flags where the patch is not yet available.
• Hunt historical logs for exploitation indicators — see Detection signatures below.

05Technical details

For the full vendor write-up, exploit chains, and reference implementations, see the references list in section 09.

06Detection signatures

Ask SARA in chat to draft a starting detection for this CVE in your stack of choice.

07Related CVEs

No directly-cited follow-up CVEs in the KB record for this advisory. The references list in section 09 carries the vendor cross-references.

08Timeline

• Published: 2020-06-29T13:56:26.000Z
• Last modified: 2024-08-05T01:47:14.141Z

09References

• www.us-cert.gov — https://www.us-cert.gov/ics/advisories/icsma-20-170-05